Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junko Ito

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Neurosurgery Practice|February 17, 2025
Diffusely Infiltrating Gliomas With Poor Prognosis, <i>TERT</i> Promotor Mutations, and Histological Anaplastic Pleomorphic Xanthoastrocytoma-Like Appearance Classify as Mesenchymal Type of Glioblastoma, IDH-wildtype by Methylation AnalysisYoshihiro Tsukamoto, Manabu Natsumeda, Haruhiko Takahashi, et al.
Endocrine Journal|July 1, 2026
Clinical characterization of Japanese children with Cushing's diseaseMari Yamamoto, Yuri Mukoyama, Kentaro Kishi, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonistsYoshio Ogino, Norikazu Ohtake, Yoshikazu Nagae, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|September 4, 2020
Characteristic terahertz absorption spectra of paramylon and paramylon-ester compoundsJunlan Zhong, Tatsuya Mori, Takanari Kashiwagi, et al.
Carbohydrate Polymers|January 19, 2020
Molecular vibration and Boson peak analysis of glucose polymers and ester via terahertz spectroscopyJunlan Zhong, Tatsuya Mori, Yasuhiro Fujii, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivativesYoshio Ogino, Norikazu Ohtake, Yoshikazu Nagae, et al.
Journal of Neuropathology and Experimental Neurology|July 29, 2024
Primary spinal cord gliomas: Pathologic features associated with prognosisYuki Tanaka, Manabu Natsumeda, Masayuki Ohashi, et al.
Obesity (Silver Spring, Md.)|April 19, 2008
Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramineSatoshi Mashiko, Akane Ishihara, Hisashi Iwaasa, et al.
Journal of Neuro-Oncology|March 3, 2019
Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumorsNozomi Matsumura, Sumihito Nobusawa, Junko Ito, et al.
Molecular Pharmacology|November 16, 2006
A pair-feeding study reveals that a Y5 antagonist causes weight loss in diet-induced obese mice by modulating food intake and energy expenditureSatoshi Mashiko, Akane Ishihara, Hisashi Iwaasa, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Neurosurgery Practice|February 17, 2025
Diffusely Infiltrating Gliomas With Poor Prognosis, <i>TERT</i> Promotor Mutations, and Histological Anaplastic Pleomorphic Xanthoastrocytoma-Like Appearance Classify as Mesenchymal Type of Glioblastoma, IDH-wildtype by Methylation AnalysisYoshihiro Tsukamoto, Manabu Natsumeda, Haruhiko Takahashi, et al.
Endocrine Journal|July 1, 2026
Clinical characterization of Japanese children with Cushing's diseaseMari Yamamoto, Yuri Mukoyama, Kentaro Kishi, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonistsYoshio Ogino, Norikazu Ohtake, Yoshikazu Nagae, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|September 4, 2020
Characteristic terahertz absorption spectra of paramylon and paramylon-ester compoundsJunlan Zhong, Tatsuya Mori, Takanari Kashiwagi, et al.
Carbohydrate Polymers|January 19, 2020
Molecular vibration and Boson peak analysis of glucose polymers and ester via terahertz spectroscopyJunlan Zhong, Tatsuya Mori, Yasuhiro Fujii, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivativesYoshio Ogino, Norikazu Ohtake, Yoshikazu Nagae, et al.
Journal of Neuropathology and Experimental Neurology|July 29, 2024
Primary spinal cord gliomas: Pathologic features associated with prognosisYuki Tanaka, Manabu Natsumeda, Masayuki Ohashi, et al.
Obesity (Silver Spring, Md.)|April 19, 2008
Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramineSatoshi Mashiko, Akane Ishihara, Hisashi Iwaasa, et al.
Journal of Neuro-Oncology|March 3, 2019
Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumorsNozomi Matsumura, Sumihito Nobusawa, Junko Ito, et al.
Molecular Pharmacology|November 16, 2006
A pair-feeding study reveals that a Y5 antagonist causes weight loss in diet-induced obese mice by modulating food intake and energy expenditureSatoshi Mashiko, Akane Ishihara, Hisashi Iwaasa, et al.
Pageof 10